NEW YORK (360Dx) – Medicortex Finland announced on Tuesday a deal with Pro-Lab Diagnostics aimed at commercializing Medicortex's brain injury detection kit in Canada and the UK.

Under the terms of the agreement Pro-Lab will shepherd the kit through the regulatory processes in Canada and the UK, as well as be responsible for clinical validation of the kit. Medicortex has granted Pro-Lab exclusive rights to sell the test in Canada and the UK in return for royalties.